Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01579994
Title Crizotinib and Ganetespib (STA-9090) in ALK Positive Lung Cancers
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center.

lung adenocarcinoma


Crizotinib + Ganetespib

Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST